Amrize Reports Strong 2025 Free Cash Flow, Proposes $1.0B Share Repurchase & Dividends, Issues Positive 2026 Guidance
AMRZ sits 35% above its 52-week low of $44.12.
Summary
Amrize Ltd. announced its Q4 and full-year 2025 results, featuring strong free cash flow and a significantly improved leverage ratio, alongside positive 2026 guidance and a substantial $1.0 billion share repurchase program with new dividends.
Key Events · Earnings and Guidance · AMRZ
-
Strong 2026 Financial Guidance
Amrize projects 4-6% revenue growth and 8-11% Adjusted EBITDA growth for full year 2026, reflecting accelerating customer demand.
-
Significant Shareholder Return Plan
The Board authorized a $1.0 billion share repurchase program and proposed both a special one-time dividend of $0.44 per share and an annual ordinary dividend of $0.44 per share, pending shareholder approval.
-
Improved Financial Health
The company reported strong Free Cash Flow of $1.5 billion for 2025 and reduced its Net Leverage Ratio to 1.1x as of December 31, 2025, down from 1.7x in Q3 2025.
-
Strategic Growth Initiatives
Amrize completed a 660,000-ton capacity expansion at its Ste. Genevieve cement plant and announced an agreement to acquire PB Materials, expanding its aggregates business into West Texas.
Analysis · AMRZ · Manufacturing
Amrize Ltd. reported mixed financial results for Q4 and full-year 2025, with revenues slightly up for the year but Adjusted EBITDA and Net Income showing declines. However, the company demonstrated strong financial health by generating $1.5 billion in Free Cash Flow and significantly reducing its Net Leverage Ratio to 1.1x. The forward-looking 2026 guidance is robust, projecting 4-6% revenue growth and 8-11% Adjusted EBITDA growth, indicating an accelerating business outlook. Furthermore, the proposed $1.0 billion share repurchase program and new dividend plan signal strong confidence from management in future performance and a commitment to returning capital to shareholders. These capital allocation decisions, combined with strategic investments in capacity expansion and M&A, suggest a positive trajectory for the company, especially as it trades near its 52-week high.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.3% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMRZ was trading at $59.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $31.7B. The 52-week trading range was $44.12 to $60.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.